AMED
Amedisys, Inc.
Set alert
- YTD
- +11.23%
- 1 year
- +3.24%
- Open
- 101.00
- Prev close
- 100.99
- Mkt cap
- 3.32B
- Vol
- 1.04M
- Avg vol
- 549.55K
- EPS
- 2.57
- P/E
- 39.30
- Div yield
- 0.00%
More statistics
- Low
- 100.93
- High
- 101.02
- Forward P/E
- 19.76
- Beta
- 0.90
- Short ratio
- 6.84
- Inst. own
- 96.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2025
- 50-d avg
- 98.01
- 200-d avg
- 93.25
- 1y target
- 0.00
Key statistics
- Market cap
- 3.32B
- Enterprise value
- 3.48B
- Trailing P/E
- 39.30
- Forward P/E
- 19.76
- PEG ratio
- 0.00
- Price / sales
- 1.38
- Price / book
- 2.69
- EPS (TTM)
- 2.57
- Beta
- 0.90
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.56%
- Revenue (TTM)
- 2.40B
- Revenue growth
- 5.20%
- Free cash flow
- 300.69M
- Total cash
- 337.30M
- Total debt
- 450.51M
- Return on equity
- 6.67%
- Shares outstanding
- 32.89M
- Short % of float
- 9.90%
- 50-day average
- 98.01
- 200-day average
- 93.25
Analyst view
Consensus: hold
- Strong buy1
- Buy0
- Hold4
- Sell1
- Strong sell0
Next earnings
Jul 29, 2025
Expected Jul 29, 2025. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 29, 2025 | Jun 1, 2025 | 1.39 | — | — | — |
| Apr 23, 2025 | Mar 1, 2025 | 1.13 | — | — | — |
| Feb 26, 2025 | Dec 1, 2024 | 1.05 | — | — | — |
| Nov 6, 2024 | Sep 1, 2024 | 1.14 | — | — | — |
| Jul 24, 2024 | Jun 1, 2024 | 1.22 | — | — | — |
| Apr 24, 2024 | Mar 1, 2024 | 1.01 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 16, 2025 | RBC Capital | reit | Outperform | Outperform |
| Mar 4, 2025 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Feb 12, 2025 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Jul 31, 2024 | Deutsche Bank | down | Buy | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | reit | Neutral | Neutral |
| Jul 1, 2024 | William Blair | down | Outperform | Market Perform |
About Amedisys, Inc.
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- amedisys.com
News
- Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Tuesday
- Earnings Scheduled For February 15, 2023
- Stocks That Hit 52-Week Lows On Tuesday
- Stocks That Hit 52-Week Lows On Friday
- Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
- Stocks That Hit 52-Week Lows On Thursday
- Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
Your note
Sign in to keep a note on AMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ASHWORTH RICHARD M | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| BOHNERT DENISE M. | Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| CAPPS VICKIE LYNN | Director | Stock Award(Grant) | May 1, 2025 | 9,818 |
| COYE MOLLY JOEL | Director | Stock Award(Grant) | May 1, 2025 | 8,818 |
| GINN SCOTT G | Chief Financial Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| GUIDROZ ALLYSON | Officer | Stock Award(Grant) | Aug 5, 2025 | 9,473 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.17% | 3,345,633 | 337.88M | Jun 29, 2025 |
| Vanguard Group Inc | 9.25% | 3,041,392 | 307.15M | Jun 29, 2025 |
| Pentwater Capital Management Lp | 5.22% | 1,715,084 | 173.21M | Jun 29, 2025 |
| FIL LTD | 3.99% | 1,312,785 | 132.58M | Jun 29, 2025 |
| Alpine Associates Management Inc. | 3.34% | 1,096,920 | 110.78M | Jun 29, 2025 |
| State Street Corporation | 3.25% | 1,067,613 | 107.82M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.25% | 1,067,364 | 107.79M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.14% | 1,032,785 | 104.30M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.49% | 818,018 | 82.61M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.61% | 529,664 | 53.49M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.53% | 504,318 | 50.93M | Mar 30, 2025 |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 1.50% | 492,439 | 49.73M | Apr 29, 2025 |